SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Purchased by Assetmark Inc.

Assetmark Inc. raised its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 72,653.0% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 589,299 shares of the exchange traded fund’s stock after buying an additional 588,489 shares during the quarter. Assetmark Inc. owned about 0.77% of SPDR S&P Biotech ETF worth $58,223,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of XBI. Mirae Asset Global Investments Co. Ltd. lifted its holdings in SPDR S&P Biotech ETF by 15.2% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 29,320 shares of the exchange traded fund’s stock valued at $2,782,000 after purchasing an additional 3,860 shares in the last quarter. Csenge Advisory Group acquired a new position in shares of SPDR S&P Biotech ETF in the first quarter valued at approximately $207,000. Geneos Wealth Management Inc. lifted its stake in shares of SPDR S&P Biotech ETF by 10.4% during the first quarter. Geneos Wealth Management Inc. now owns 1,541 shares of the exchange traded fund’s stock valued at $146,000 after buying an additional 145 shares during the period. Quantbot Technologies LP acquired a new stake in SPDR S&P Biotech ETF during the first quarter worth approximately $2,237,000. Finally, Nvwm LLC grew its stake in SPDR S&P Biotech ETF by 28.5% in the 1st quarter. Nvwm LLC now owns 6,139 shares of the exchange traded fund’s stock worth $583,000 after acquiring an additional 1,361 shares during the period.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI opened at $104.18 on Friday. SPDR S&P Biotech ETF has a fifty-two week low of $64.99 and a fifty-two week high of $104.22. The company has a market capitalization of $7.94 billion, a PE ratio of 11.47 and a beta of 1.11. The stock has a fifty day moving average of $98.96 and a two-hundred day moving average of $95.52.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.